| Aug 1 |
Compared to Estimates, Regeneron (REGN) Q2 Earnings: A Look at Key Metrics
|
| Aug 1 |
Regeneron (REGN) Tops on Q2 Earnings, Eylea HD, Dupixent Fuel Sales
|
| Aug 1 |
Regeneron beats quarterly results on strong demand for eczema, eye treatments
|
| Aug 1 |
Regeneron beats in Q2 as Eylea tops expectations
|
| Aug 1 |
Regeneron Stock Climbs After Strong Second-Quarter Performance
|
| Aug 1 |
Regeneron (REGN) Surpasses Q2 Earnings and Revenue Estimates
|
| Aug 1 |
Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November
|
| Aug 1 |
Regeneron: Q2 Earnings Snapshot
|
| Aug 1 |
Regeneron Pharmaceuticals Non-GAAP EPS of $11.56 beats by $0.94, revenue of $3.55B beats by $160M
|
| Aug 1 |
Regeneron Reports Second Quarter 2024 Financial and Operating Results
|
